These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7808178)

  • 21. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F
    Z Allgemeinmed; 1974 Apr; 50(11):535-7. PubMed ID: 4135074
    [No Abstract]   [Full Text] [Related]  

  • 22. Reversible cardiomyopathy due to chronic use of xylometazoline topical nasal spray.
    Figueiras-Graillet LM; Martínez-Sellés M; Perez-David E; Fernandez-Avilés F
    Int J Cardiol; 2013 Apr; 164(2):e17-8. PubMed ID: 23079093
    [No Abstract]   [Full Text] [Related]  

  • 23. Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic.
    Isaacson G; Buttaro BA; Mazeffa V; Li G; Frenz DA
    Ann Otol Rhinol Laryngol; 2005 Aug; 114(8):645-51. PubMed ID: 16190099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal respiratory distress from rhinitis medicamentosa.
    Osguthorpe JD; Shirley R
    Laryngoscope; 1987 Jul; 97(7 Pt 1):829-31. PubMed ID: 2439862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rhinitis medicamentosa].
    Finsnes KA
    Tidsskr Nor Laegeforen; 1987 Jun; 107(17-18):1558-9. PubMed ID: 2440127
    [No Abstract]   [Full Text] [Related]  

  • 26. [Alpha-2-agonists: everyday anesthetic treatment in veterinary medicine, but far from safe. The consequences of accidental self injection].
    Hoyer MJ
    Tijdschr Diergeneeskd; 2006 Mar; 131(6):193-4. PubMed ID: 16613236
    [No Abstract]   [Full Text] [Related]  

  • 27. [Symptoms and therapy for pregnancy rhinitis].
    Hoffmann TK; Wagenmann M; Kojda G; Bender HG; Friebe-Hoffmann U
    Z Geburtshilfe Neonatol; 2004 Aug; 208(4):126-32. PubMed ID: 15326554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea.
    Hoover RM; Erramouspe J
    Ann Pharmacother; 2018 Mar; 52(3):263-267. PubMed ID: 29094614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative distribution study of two procedures for administration of nose drops.
    Morén F; Björnek K; Klint T; Wagner ZG
    Acta Otolaryngol; 1988; 106(3-4):286-90. PubMed ID: 3176972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nose drops can induce cerebral reactions in children].
    Söderman P; Sahlberg D; Wiholm BE
    Lakartidningen; 1983 Sep; 80(37):3286-7. PubMed ID: 6633062
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison between xylometazoline in a dosage spray and oxymetazoline in one dose pipettes].
    Petruson B; Ekedahl C; Geterud A; Aust R; Odkvist L
    Lakartidningen; 1983 May; 80(18):1908-10. PubMed ID: 6350765
    [No Abstract]   [Full Text] [Related]  

  • 32. Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray.
    Glazener F; Blake K; Gradman M
    N Engl J Med; 1983 Sep; 309(12):731. PubMed ID: 6888446
    [No Abstract]   [Full Text] [Related]  

  • 33. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhinopathia medicamentosa.
    Rijntjes E
    Rhinology; 1982 Mar; 20(1):49-51. PubMed ID: 6176003
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical oxymetazoline hydrochloride 0.05% as a strategy to reduce intraoperative wound oozing in Mohs micrographic surgery.
    Phillips CB; Huang CC
    Dermatol Surg; 2015 Jun; 41(6):749-50. PubMed ID: 25984903
    [No Abstract]   [Full Text] [Related]  

  • 36. [Daily administration of nose drops can cause chronic nasal congestion].
    Graf P; Hallén H
    Lakartidningen; 1996 Jan; 93(4):259-62. PubMed ID: 8569350
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rhinitis medicamentosa: an increasing therapeutical problem].
    Betlejewski S
    Otolaryngol Pol; 1997; 51(1):53-7. PubMed ID: 9518316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse reactions to oxymetazoline.
    Silverman HI
    Lancet; 1984 Aug; 2(8398):347-8. PubMed ID: 6146886
    [No Abstract]   [Full Text] [Related]  

  • 39. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term treatment with nose drops containing xylometazoline].
    Petruson B
    Lakartidningen; 1981 Jan; 78(3):114-6. PubMed ID: 7206938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.